| 13510 |
11-deoxy Prostaglandin E1
Exclusive |
|
37786-00-8 |
>96%
|
|
✓ |
|
52.050220994475
|
11-deoxy-prostaglandin-e1
|
11-deoxy PGE1
|
11-deoxy-PGE1 prostaglandins agonists analogs EP2 receptors |
| 16520 |
11β-Prostaglandin F2α
|
|
38432-87-0 |
>99%
|
|
|
|
46.084212707182
|
11-prostaglandin-f2
|
11β-PGF2α
|
11.beta.-PGF2.alpha. 11beta-PGF2alpha metabolites PGD2 prostaglandins 9.beta.-11-deoxy-PGF2.alpha. 9beta-11-deoxy-PGF2alpha 9b-11-deoxy-PGF2alpha |
| 516521 |
11β-Prostaglandin F2α EIA Kit
|
|
- |
|
|
|
|
181.804827348066
|
11-prostaglandin-f2-eia-kit
|
11β-Prostaglandin F2α ELISA Kit
|
solid plates metabolites mastocytosis 11beta-PGF2alpha prostaglandins measures kits eias enzyme immunoassays ELISAs 11.beta.-PGF2.alpha. 11b-PGF2alpha assays |
| 20150 |
14,15-dehydro Leukotriene B4
|
|
114616-11-4 |
>97%
|
|
|
2008-06-02
|
62.879535911602
|
14-15-dehydro-leukotriene-b4
|
14,15-dehydro LTB4
|
leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition |
| 10011360 |
14,15-Leukotriene C4
|
|
75290-60-7 |
>95%
|
|
|
2008-05-23
|
59.626648250460
|
14-15-leukotriene-c4
|
EXC4; Eoxin C4; 14,15-LTC4
|
leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory |
| 10011362 |
14,15-Leukotriene E4
|
|
1000852-57-2 |
≥97%
|
|
|
2008-11-15
|
51.130631412785
|
14-15-leukotriene-e4
|
14,15-LTE4; EXE4; Eoxin E4
|
leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes |
| 34720 |
15(S)-HETE
|
|
54845-95-3 |
≥98%
|
|
|
|
41.036397000789
|
15-s-hete
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs |
| 334720 |
15(S)-HETE-d8
|
|
84807-87-4 |
≥99% deuterated product
|
|
|
|
44.654696132596
|
15-s-hete-d8
|
|
GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE |
| 534721 |
15(S)-HETE EIA Kit
|
|
- |
|
|
|
|
81.124019337016
|
15-s-hete-eia-kit
|
15(S)-HETE ELISA Kit
|
15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays |
| 10007251 |
15(S)-HETE Lipid Maps MS Standard
|
|
54845-95-3 |
≥98%
|
|
|
2009-02-17
|
19.556098597535
|
15-s-hete-lipid-maps-ms-standard
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE |
| 10009638 |
5-Lipoxygenase (human recombinant) Western Ready Control
|
|
- |
78 kDa (His-tagged), 74 kDa (native)
|
|
|
2007-07-27
|
13.397679558010
|
5-lipoxygenase-human-recombinant-western-ready-control
|
5-LOX; 5-LO
|
western blot WB 5(S)-HETE arachidonic acids leukotrienes rat basophilic leukemia alveolar eosinophils mast epithelial lungs blood |
| 10007820 |
5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody
|
|
- |
|
|
|
2006-09-13
|
4.215519839276
|
5-lipoxygenase-phospho-ser523-polyclonal-antibody
|
5-LO (Phospho-Ser523) Polyclonal Antibody
|
wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting |
| 10006618 |
5-OxoETE Receptor Blocking Peptide
|
|
- |
|
|
|
2005-03-07
|
0E-12
|
5-oxoete-receptor-blocking-peptide
|
TG1019; R527
|
antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty |
| 100025 |
5-OxoETE Receptor Polyclonal Antibody
|
|
- |
|
|
|
2004-12-14
|
206.269410681399
|
5-oxoete-receptor-polyclonal-antibody
|
TG1019; R527
|
WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting |
| 10005032 |
5(S),6(R)-7-trihydroxymethyl Heptanoate
|
|
- |
>95%
|
|
|
2007-06-13
|
94.367734806629
|
5-s-6-r-7-trihydroxymethyl-heptanoate
|
BML-111
|
lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear |
| 10008640 |
Asthma Treatment Standard Set
|
|
- |
|
|
|
2006-07-13
|
8.559116022100
|
asthma-treatment-standard-set
|
|
CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction montelukast pranlukast zafirlukast zileuton 10006967 packs |
| 13160 |
AT-56
Exclusive New |
|
162640-98-4 |
≥95%
|
|
✓ |
2010-06-22
|
7.811430325353
|
at-56
|
|
Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid |
| 10156 |
BAY-u3405
|
|
116649-85-5 |
>98%
|
|
|
2004-11-17
|
38.910566298342
|
bay-u3405
|
Ramatroban
|
human medications allergic rhinitis antagonists thromboxanes TP receptors DP2/CRTH2 prostaglandins PGD2 7-transmembrane GPCRs G-protein-coupled BAYu3405 |
| 10009599 |
Calcipotriol (hydrate)
|
|
112828-00-9 |
>98%
|
|
|
2008-02-08
|
41.228011049724
|
calcipotriol-hydrate
|
Calcipotriene (hydrate)
|
vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response |
| 10006735 |
CAY10471
|
|
627865-18-3 |
≥98%
|
|
|
2005-06-22
|
35.209602209944
|
cay10471
|
|
ramatroban DP2 CRTH2 antagonists TP receptors prostaglandins PGD2 7-transmembranes GPCRs G protein-coupled BAY-u3405 human medications allergic rhinitis analogs |
| 13164 |
CAY10589
Exclusive |
|
1077626-52-8 |
≥98%
|
|
✓ |
2009-06-23
|
4.758468823994
|
cay10589
|
|
Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling |
| 13381 |
CAY10606
|
|
1159576-98-3 |
≥98%
|
|
|
2009-12-04
|
134.825417754897
|
cay10606
|
|
5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition |
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8)
|
|
- |
|
|
|
2008-09-03
|
3.397790055249
|
cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8
|
|
antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 |
| 13183 |
CP 80633
New |
|
135637-46-6 |
≥98%
|
|
|
2010-05-20
|
4.657237569061
|
cp-80633
|
|
phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 |
| 500390 |
Cysteinyl Leukotriene EIA Kit
New |
|
- |
|
|
|
2010-08-30
|
0E-12
|
cysteinyl-leukotriene-eia-kit
|
CysLT ELISA Kit
|
cys LTs solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs |
| 10009291 |
Cysteinyl Leukotriene Express EIA Kit
|
|
- |
|
|
|
2008-08-11
|
149.125071823204
|
cysteinyl-leukotriene-express-eia-kit
|
CysLT Express ELISA Kit
|
solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs |
| 101640 |
DP1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
2004-10-22
|
27.251933701657
|
dp1-receptor-polyclonal-antibody
|
Prostaglandin D2 Receptor 1; PGD2 Receptor 1
|
isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting |
| 10009162 |
GW 627368X
Exclusive |
|
439288-66-1 |
≥96%
|
|
✓ |
2007-05-14
|
66.524401473296
|
gw-627368x
|
|
EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X |
| 10134 |
HQL-79
|
|
162641-16-9 |
>98%
|
|
|
|
191.117734806629
|
hql-79
|
|
inhibitors prostaglandins synthases PGD2 L-PGDS tetrazoles HQL79 inhibits lipocalin-type |
| 10006198 |
Leukotriene C4-d5
|
|
- |
≥99% deuterated product
|
|
|
2007-04-11
|
74.926850828729
|
leukotriene-c4-d5
|
LTC4-d5
|
cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry |
| 10007164 |
Leukotriene C4 methyl ester
|
|
73958-10-8 |
>97%
|
|
|
2005-11-23
|
26.793093922651
|
leukotriene-c4-methyl-ester
|
LTC4 methyl ester
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs cysLTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble |
| 10006199 |
Leukotriene D4-d5
|
|
- |
≥99% deuterated product
|
|
|
2008-04-23
|
48.846740331491
|
leukotriene-d4-d5
|
LTD4-d5
|
peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry |
| 10007165 |
Leukotriene D4 methyl ester
|
|
- |
>97%
|
|
|
2005-09-07
|
40.398195211786
|
leukotriene-d4-methyl-ester
|
|
cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes asthma SRS-A bronchoconstriction peptido-leukotrienes slow-reacting substance anaphylaxis allergy metabolites acute hypersensitivity vascular permeability |
| 10007858 |
Leukotriene E4-d5
|
|
- |
≥99% deuterated product
|
|
|
2008-04-08
|
92.945690607734
|
leukotriene-e4-d5
|
LTE4-D5
|
peptido-leukotrienes LTE4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes deuterated deuterium cysLTs GC/MS GC-MS LC/MS LC-MS mass spectrometry |
| 10007166 |
Leukotriene E4 methyl ester
|
|
- |
>97%
|
|
|
2005-10-25
|
19.544883977900
|
leukotriene-e4-methyl-ester
|
|
peptido-leukotrienes LTD4 asthma urine uninary allergy SRS-A slow-reacting substance anaphylaxis cysteinyl-LTs peptido-LTs cys-LTs cysteinyl-leukotrienes fatty acids backbone dipeptidases plasma lipids soluble |
| 390150 |
Linoleic Acid-d4
Exclusive |
|
79050-23-0 |
≥99% deuterated product
|
|
✓ |
|
18.640441988949
|
linoleic-acid-d4
|
|
standards deuterated deuterium GC/MS internal isotopes GC-MS LC/MS LC-MS mass spectrometry fatty acids |
| 10007577 |
Luminex® Cysteinyl Leukotriene Kit
|
|
- |
|
|
|
2006-12-01
|
78.963499079189
|
luminex-cysteinyl-leukotriene-kit
|
|
cys-LTs LTC4 LTD4 LTE4 measures kits asthma peptido-lts peptido-leukotrienes cysteinyl-leukotrienes allergy cysteinyl-LTs luminex xMAP beads kits assays |
| 500260 |
Luminex® Leukotriene B4 Kit
|
|
- |
|
|
|
2008-11-12
|
41.254088397790
|
luminex-leukotriene-b4-kit
|
Luminex® LTB4 Kit
|
leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays |
| 10007502 |
Luminex® Thromboxane B2 Kit
|
|
- |
|
|
|
2009-07-13
|
27.665414364640
|
luminex-thromboxane-b2-kit
|
Luminex® TXB2 Kit
|
thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays |
| 10009835 |
MK 0524
|
|
571170-77-9 |
>98%
|
|
|
2008-05-06
|
62.451239147592
|
mk-0524
|
Laropiprant
|
antagonist PGD2 allergy asthma DP1 niacin vasodilations flushing dyslipidemia receptors atherosclerosis hypertension inflammation mk0524 |
| 10008318 |
Montelukast (sodium salt)
|
|
151767-02-1 |
>98%
|
|
|
2006-04-20
|
29.358508287293
|
montelukast-sodium-salt
|
Singulair®
|
cysteinyl-leukotrienes cysLT1 receptors antagonists LTC4 LTD4 mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries protein-coupled GPCRs selective potent |
| 13390 |
N-methyl Leukotriene C4
|
|
131391-65-6 |
>97%
|
|
|
2008-10-15
|
81.831694290976
|
n-methyl-leukotriene-c4
|
N-methyl LTC4
|
allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics |
| 360900 |
PAF C-16-d4
|
|
- |
≥99% deuterated product
|
|
|
|
17.036574585636
|
paf-c-16-d4
|
Platelet-activating Factor C-16-d4
|
PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis |
| 10008319 |
Pranlukast
|
|
103177-37-3 |
>98%
|
|
|
2006-05-23
|
16.435161799526
|
pranlukast
|
Ultair; ONO-1078
|
CysLT1 receptors cysteinyl leukotrienes asthma allergy antagonists LTC4 LTD4 hypersensitivity oral peptidyl LTRA bronchoconstriction |
| 12010 |
Prostaglandin D2
|
|
41598-07-6 |
>99%
|
|
|
|
109.955638428484
|
prostaglandin-d2
|
PGD2
|
Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry |
| 10010123 |
Prostaglandin D2-d9
|
|
- |
≥99% deuterated product
|
|
|
2007-10-25
|
54.458176795580
|
prostaglandin-d2-d9
|
PGD2-d9
|
GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma |
| 512031 |
Prostaglandin D2 EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 512041 |
Prostaglandin D2 Express EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 500581 |
Prostaglandin D2 FPIA Kit - Green
|
|
- |
|
|
|
2004-11-16
|
61.908493219487
|
prostaglandin-d2-fpia-kit-green
|
PGD2 Fluorescence Polarization Immunoassay - Green
|
PGD2 metabolites prostaglandins immunoassays HTS high-throughput kits screenings rapid measurements assays |
| 10007835 |
Prostaglandin D2 FPIA Kit - Red
|
|
- |
|
|
|
2007-09-07
|
101.043268876611
|
prostaglandin-d2-fpia-kit-red
|
PGD2 Fluorescence Polarization Immunoassay - Red
|
PGD2 metabolites prostaglandins immunoassays HTS high-throughput kits screenings rapid measurements assays |
| 10007202 |
Prostaglandin D2 Lipid Maps MS Standard
|
|
41598-07-6 |
>99%
|
|
|
2008-10-27
|
28.090560985975
|
prostaglandin-d2-lipid-maps-ms-standard
|
PGD2
|
Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS |
| 600007 |
Prostaglandin D Synthase (hematopoietic-type) FP-Based Inhibitor Screening Assay Kit - Green
|
|
- |
|
|
|
2009-01-21
|
82.026804788213
|
prostaglandin-d-synthase-hematopoietic-type-fp-based-inhibitor-screening-assay-kit-green
|
H-PGDS FP-Based Inhibitor Screening Assay Kit - Green; Prostaglandin D Synthase (hematopoietic-type) Fluorescence Polarization-Based Inhibitor Screening Assay Kit - Green
|
assays kits measures measurements FPs fluorescent fluorescences polarizations polarization-based inhibitors inhibits inhibition prostaglandins synthases pgs H-PGDS PGD2 lipocalin-types L-PGDS allergies allergy allergic inflammatory inflammations reactions mast Th2 microglia necrotic muscles fibers apoptotic smooth HQL-79 tranilast guinea pigs lungs tissues pyrimidines amides amide-based single step fluoresceins probes Z' dynamic ranges mP units BSPTfluorescently-labeled HPGDS H-PGDS assays |
| 10006593 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant)
|
|
- |
>95%
|
|
|
2005-02-16
|
29.085078926597
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant
|
Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant)
|
prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators |
| 10009625 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-07-19
|
14.622651933701
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control
|
Hematopoietic-PGDS; H-PGDS
|
western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli |
| 10004347 |
Prostaglandin D Synthase (hematopoietic-type; murine recombinant)
Exclusive |
|
- |
>85%
|
|
✓ |
2008-06-05
|
63.483990178023
|
prostaglandin-d-synthase-hematopoietic-type-murine-recombinant
|
H-PGDS; Hematopoietic-PGDS
|
PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS |
| 10006595 |
Prostaglandin D Synthase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2005-08-31
|
54.944638253091
|
prostaglandin-d-synthase-inhibitor-screening-assay-kit
|
PGDS Inhibitor Screening Assay Kit
|
prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS |
| 10006788 |
Prostaglandin D Synthase (lipocalin-type; human recombinant)
|
|
- |
>95%
|
|
|
2005-03-23
|
63.418876611417
|
prostaglandin-d-synthase-lipocalin-type-human-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
| 10006787 |
Prostaglandin D Synthase (lipocalin-type; murine recombinant)
|
|
- |
>95%
|
|
|
2005-03-23
|
67.890623984400
|
prostaglandin-d-synthase-lipocalin-type-murine-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
| 10010548 |
Prostaglandin D Synthase (lipocalin-type; rat recombinant)
Exclusive |
|
- |
>95%
|
|
✓ |
2008-07-01
|
73.268771780705
|
prostaglandin-d-synthase-lipocalin-type-rat-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds |
| 13020 |
Prostaglandin E1 Alcohol
Exclusive |
|
21562-57-2 |
>99%
|
|
✓ |
|
24.256022099447
|
prostaglandin-e1-alcohol
|
1-hydroxy Prostaglandin E1; PGE1 Alcohol
|
PGE1 alcohols agonists prostaglandins EP2 EP4 receptors |
| 13294 |
Pyrrophenone
Exclusive New |
|
341973-06-6 |
≥90%
|
|
✓ |
2010-04-07
|
51.367941988950
|
pyrrophenone
|
|
phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory |
| 10012554 |
Resolvin D1
Exclusive |
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
349.448176795580
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins |
| 10011132 |
Rolipram
|
|
61413-54-5 |
≥98%
|
|
|
2008-12-16
|
5.263867403315
|
rolipram
|
ZK 62711; SB 95952
|
inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss |
| 13343 |
RSC-3388
|
|
337307-06-9 |
≥95%
|
|
|
2010-02-15
|
61.004162062615
|
rsc-3388
|
|
cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis |
| 12850 |
tetranor-PGDM
Exclusive |
|
133161-96-3 |
>98%
|
|
✓ |
2008-04-08
|
50.454397790055
|
tetranor-pgdm
|
tetranor-Prostaglandin D Metabolite
|
metabolites urinary PGD2 prostaglandins D2 urine |
| 10009039 |
tetranor-PGDM-d6
|
|
- |
≥99% deuterated product
|
|
|
2007-06-28
|
19.476229281767
|
tetranor-pgdm-d6
|
tetranor-Prostaglandin D Metabolite-d6
|
deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry |
| 501001 |
tetranor-PGDM EIA Kit
Exclusive |
|
- |
|
|
✓ |
2009-06-15
|
76.961691457713
|
tetranor-pgdm-eia-kit
|
tetranor-Prostaglandin D Metabolite ELISA Kit
|
prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays |
| 501002 |
tetranor-PGDM EIA Kit (Solid Plate)
Exclusive |
|
- |
|
|
✓ |
2009-06-15
|
66.595588610284
|
tetranor-pgdm-eia-kit-solid-plate
|
tetranor-Prostaglandin D Metabolite ELISA Kit (Solid Plate)
|
prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays |
| 10012559 |
TP Receptor (human) Polyclonal FITC Antibody
|
|
- |
|
|
|
2008-07-25
|
70.520841006752
|
tp-receptor-human-polyclonal-fitc-antibody
|
TXA2 Receptor; Thromboxane A2 Receptor
|
antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IFimmunofluorescence western blots blotting WB immunoblotting |
| 13044 |
Tranilast
|
|
53902-12-8 |
≥98%
|
|
|
2008-08-29
|
14.231767955801
|
tranilast
|
SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid
|
anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF |
| 10010519 |
Vialinin A
|
|
858134-23-3 |
≥98%
|
|
|
2008-07-25
|
77.693314917127
|
vialinin-a
|
Terrestrin A
|
.beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant |
| 13246 |
YM-58483
|
|
223499-30-7 |
≥98%
|
|
|
2009-11-16
|
5.585937500000
|
ym-58483
|
BTP 2
|
calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT |
| 13665 |
YS121
Exclusive New |
|
916482-17-2 |
≥98%
|
|
✓ |
2010-04-02
|
15.062066298342
|
ys121
|
|
Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition inhibits PGs YS 121 YS-121 |
| 10008282 |
Zafirlukast
|
|
107753-78-6 |
>97%
|
|
|
2006-05-01
|
10.771319060773
|
zafirlukast
|
Accolate®
|
cysteinyl-leukotrienes cysLT1 receptors GPCRs protein-coupled antagonists asthma asthmatic allergies allergic rhinitis selective cysLTs cys-LTs cys-LT1 accolate™ |